Cannabis News and Research

Latest Cannabis News and Research

Cognitive Behaviour Therapy, a rapid, targeted, drug-free treatment option for depression

Initial results from a pilot study conducted by HMRI researchers based at the University of Newcastle suggest that there is an unmet treatment need for people suffering from depression and co-existing drug and alcohol problems.

21 Jun 2004

Marijuana/Cannabis causes transient schizophrenia-like symptoms

The principal active ingredient in marijuana causes transient schizophrenia-like symptoms ranging from suspiciousness and delusions to impairments in memory and attention, according to a Yale research study.

15 Jun 2004

Cannabis extract drug may help patients with rheumatoid arthritis

The multi centre double blind, randomised, parallel group study in 58 patients assessed the efficacy, safety and tolerability of Sativex®, a whole plant medicinal cannabis extract, compared with placebo for the treatment of pain caused by Rheumatoid Arthritis. Study medication was administered by means of a spray into the mouth as an evening dose only and measures were assessed the following day.

11 Jun 2004

Revealing new insights into young people's health

A report published by the WHO Regional Office for Europe gives revealing new insights into aspects of young people's lives that can help or harm their health.

7 Jun 2004

New book highlights pros and cons of medical use of cannabis

A new book which brings together the relevant science regarding the beneficial effects of cannabis for identified medical conditions and explains many harmful side effects has been launched at Australia's Southern Cross University today.

19 May 2004

Male cannabis users are needed for an Australian study

Psychiatry Department researchers are seeking men who have used cannabis during the last month, have no history of psychiatric treatment, live within 20kms of the CBD and are aged over 18.

18 May 2004

More evidence is required to associate cannabis use with negative psychosocial effects

University of Birmingham researchers conclude that more evidence is required to determine the nature and extent of associating cannabis use with negative psychosocial effects.

14 May 2004

New Canadian drug submission for cannabis-based medicine

GW Pharmaceuticals and Bayer HealthCare, Pharmaceuticals Division - Canada have announced that GW has submitted a New Drug Submission for Sativex®, a cannabis-based medicinal extract product, to Health Canada.

13 May 2004

Study suggest that decriminalization of marijuana does not lead to increased drug use

In the first rigorous study comparing marijuana use in the Netherlands and the United States, researchers have found no evidence that decriminalization of marijuana leads to increased drug use. The results suggest that drug policies may have less impact on marijuana use than is currently thought.

3 May 2004